Drooid Logo
Back to story perspectives

Full Breakdown

Influencer Igho “Tiny” Ubiribo Dies After Botched Penis Enlargement Procedure in Thailand

9/6/2026, 11:18:37 AM

Core Event

British-Nigerian influencer Igho “Tiny” Ubiribo, 43, underwent a penile enlargement injection while on vacation in Bangkok on March 5. Shortly after the procedure, he and his wife Daniella Simba Allen (spelled “Danielle” in some reports) experienced chest pain during a hotel massage, lost consciousness twice, and were rushed to Sukhumvit Hospital. Despite more than 100 minutes of CPR, Ubiribo died of a pulmonary embolism before a diagnostic CT scan could be performed.

Background & Context

Ubiribo, known on Instagram as @ego2222 and also as “Denisi” or “Ego,” documented a lavish lifestyle that included a $1.1 million home in Los Angeles and a $600,000 London apartment. The procedure involved injecting a filler—hyaluronic acid combined with lidocaine—into the penis, a cosmetic practice marketed to increase length or girth but associated with risks such as infection, scarring, and vascular complications.

Data & Statistics

  • Instagram following: ~185,000 users.
  • Reported filler volume: 40 milliliters (one source) or 40 mm (another source).
  • Hyaluronic-acid penile fillers can cost up to $9,000 and typically last six to nine months.
  • Post-mortem burial: a gold-coated coffin valued at ? $745,000.

Official Statements & Responses

Coroner Jean Harkin of the Inner West London Coroners’ Court confirmed that the hyaluronic acid and lidocaine injection caused the embolism that led to Ubiribo’s death. The autopsy identified the filler material in the lungs, indicating migration from the injection site. The coroner’s report has not been released publicly, and the Inner West London Coroner’s Court did not respond to requests for the full post-mortem documentation.

Conflicting Reports & Gaps

  • The spouse’s name appears as Daniella in the New York Post and Danielle in eonline and The Nightly.
  • The quantity of filler is described as 40 milliliters in two outlets and 40 mm in another, reflecting inconsistent reporting.
  • No clinic name or specific medical provider was identified in any source, leaving the procedural setting undocumented.

The case underscores the medical risks associated with elective cosmetic procedures performed abroad, particularly when involving injectable fillers in sensitive anatomical areas.